← Leaderboards
Barbara A Swanson
Rush University Medical Center
$1,307,703
Attributed
$1,307,703
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $222K · FY2005–16$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$1,307,703 · 2
By mechanism
P20$729,958 · 1
R21$577,745 · 1
Top collaborators
No co-investigators on record.
Most similar at Rush University Medical Center
Same institution · by research overlap
- Martha C. Morris$22,587,904
- Papasani V Subbaiah$6,546,593
- Judith L Luborsky$2,011,504
- Audrey French$22,166,690
Others in their field
Top investigators on “Serum”
- Joseph B. Margolick · Johns Hopkins University$72,041,404
- Monica M Bertagnolli · Strang Cancer Prevention Center$59,344,476
- Leonardo Trasande · New York University School Of Medicine$53,176,255
- Bradley F Boeve · Mayo Clinic Rochester$50,650,130
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$50,055,104
- Laurence H Baker · University Of Michigan At Ann Arbor$48,684,161
Research focus
SerumPersonsHiv InfectionsInflammationImmuneInfectionInstructionCohort StudiesElderlyAids/Hiv ProblemHeart DiseasesAge GroupAfrican AmericanAnti-InflammatoryAnti-Inflammatory AgentsComorbidityAge Of OnsetChronicAgingCytokineCardiacCardiovascular DiseasesHealth StatusFish Oils
Grant awards (8)
Fish oil for HIV- Related Infiamm-aging and Immune Senescence$155,788
P20 · FY2016 · MD · contact PI
Fish oil for HIV- Related Infiamm-aging and Immune Senescence$155,282
P20 · FY2015 · MD · contact PI
Fish oil for HIV- Related Infiamm-aging and Immune Senescence$160,520
P20 · FY2014 · MD · contact PI
Fish oil for HIV- Related Infiamm-aging and Immune Senescence$77,347
P20 · FY2013 · MD · contact PI
Fish oil for HIV- Related Infiamm-aging and Immune Senescence$181,021
P20 · FY2012 · MD · contact PI
Preliminary Study of Safety and Efficacy of Policosanol for Dyslipidemia in HIV$175,092
R21 · FY2007 · AT · contact PI
Preliminary Study of Safety and Efficacy of Policosanol$180,653
R21 · FY2006 · AT · contact PI
Preliminary Study of Safety and Efficacy of Policosanol$222,000
R21 · FY2005 · AT